Editorial label review
Midi Health side effects: mood swings
Primary formulary: Estradiol (patch, pill, gel) + micronized progesterone; paroxetine 7.5 mg (Brisdelle); fezolinetant (Veozah)
Quick answer
Mood swings shows up on the FDA labels for the active ingredients Midi Health prescribes — Estradiol (patch, pill, gel) + micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.
What Midi Health prescribes and why it matters for mood swings
Midi Health prescribes FDA-approved estradiol and progesterone plus non-hormonal options — paroxetine 7.5 mg (Brisdelle) and fezolinetant (Veozah) — for patients who cannot or prefer not to use estrogen. Because Midi Health prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Mood-disturbance entries appear on estradiol, progesterone, and paroxetine PIL surfaces.
Common label-level side effects
Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.
- "Mood disturbance" and "emotional lability" are listed at 2–6% on estradiol-progestin combination PIL Section 6 tables
- Prometrium PIL Section 5.6 requires evaluation for depression, mood change, or irritability during therapy
- Label narrative notes mood swings often peak in the first 2–3 cycles before stabilising — not a comparative efficacy claim
Serious label-level warnings
Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.
- Severe or persistent mood change — the Prometrium label instructs discontinuation if serious depression recurs
- New suicidal thoughts on paroxetine — FDA class boxed warning applies to Brisdelle
When to contact your clinician
Contact your clinician same-day if mood change is severe, persistent, or paired with any suicidal thoughts — both progesterone and paroxetine labels require urgent review.
Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.
What to ask your provider
- “Which SKU in the Midi Health formulary am I on, and what is its labelled frequency for mood swings?”
- “Is my mood swingslikely a labelled adverse reaction, or something separate that needs its own workup?”
- “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
- “What is the plan if mood swingsdoes not settle within 2–3 cycles?”
Related editorial reading
- Full editorial review of Midi Health — formulary, pricing, and clinician model.
- Is mood swings caused by menopause itself? — how the transition presents on its own.
- Estradiol medication page — mechanism, dosing, and full PIL notes.
- Paroxetine low dose medication page — secondary ingredient in Midi Health's formulary.
- Browse all side-effect matrix pages — 4 brands × 15 symptoms.
Frequently asked questions
- How often does mood swings happen on Midi Health?
- Midi Health's primary regimen — Estradiol (patch, pill, gel) + micronized progesterone; paroxetine 7.5 mg (Brisdelle); fezolinetant (Veozah) — carries the FDA-labelled adverse-reaction frequencies for mood swings described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
- When should I stop Midi Health because of mood swings?
- Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
- Is mood swings on the FDA label for Midi Health's medications?
- Mood-disturbance entries appear on estradiol, progesterone, and paroxetine PIL surfaces.
- Is mood swings caused by menopause itself?
- Mood swings can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/mood-swings explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.
Sources
- FDAFDA-approved label — Estrace (estradiol) via DailyMed
- FDAFDA-approved label — Vivelle-Dot (estradiol transdermal) via DailyMed
- FDAFDA-approved label — Prometrium (micronized progesterone) via DailyMed
- FDAFDA-approved label — Brisdelle (paroxetine 7.5 mg) via DailyMed
- FDAFDA-approved label — Veozah (fezolinetant) via DailyMed